MICHAEL W ROGERS Insider Trading $EYPT EyePoint Pharmaceuticals, Inc.
Get free email notifications about insider trading for MICHAEL W ROGERS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W ROGERS. MICHAEL W ROGERS is Executive Vice President in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Chief Financial Officer in ACORDA THERAPEUTICS INC ($ACOR) and in EyePoint Pharmaceuticals, Inc. ($EYPT) and Director in pSivida Corp. ($PSDV) and Chief Financial Officer in Aerpio Pharmaceuticals, Inc. ($ZETAII) and Director in Aravive, Inc. ($ARAV) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
MICHAEL W ROGERS in EyePoint Pharmaceuticals, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of MICHAEL W ROGERS:
Holdings: 119,167 shares
Current Value: $197,817
Latest Transaction: Jun 27 2019
$EYPT Market Capitalization: $60.15M
$EYPT Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W ROGERS in EyePoint Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACOR, ARPO, AKBA, ARAV, IDEV, EYPT, KERX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Option Exercise | A | 2.65 | 40,000 | 106,000 | 40,000 | ||
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Option Exercise | M | 0.00 | 6,667 | 0 | 0 | ||
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Buy | M | 0.00 | 6,667 | 0 | 119,167 | 112.5 K to 119.2 K (+5.93 %) | |
| Nov 16 2018 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Option Exercise | M | 1.13 | 100,000 | 113,000 | 0 | |
| Nov 16 2018 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Buy | M | 1.13 | 100,000 | 113,000 | 112,500 | 12.5 K to 112.5 K (+800.00 %) |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Option Exercise | A | 0.00 | 6,667 | 0 | 6,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Option Exercise | A | 1.95 | 26,667 | 52,001 | 26,667 | |
| Dec 19 2017 | PSDV | pSivida Corp. | ROGERS MICHAEL W | Director | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
| Dec 19 2017 | PSDV | pSivida Corp. | ROGERS MICHAEL W | Director | Option Exercise | A | 1.77 | 20,000 | 35,400 | 20,000 | |
| Dec 14 2016 | PSDV | pSivida Corp. | ROGERS MICHAEL W | Director | Option Exercise | A | 3.49 | 20,000 | 69,800 | 20,000 | |
| Dec 04 2015 | PSDV | pSivida Corp. | ROGERS MICHAEL W | Director | Option Exercise | A | 4.09 | 20,000 | 81,800 | 20,000 |
Page: 1